Federal funding analysis
Reported transaction obligations
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 3 of 3 selected awards have dated, valued transactions.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $12.7M |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $34.4M |
| Change | $-21.7M |
| Growth | -63.1%Why this funding changeNet obligations in equal-length adjacent periods. ($12,676,870.00 − $34,384,111.00) ÷ $34,384,111.00 × 100 = -63.13%
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Negative obligation adjustments can produce a decline below −100%. |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Health and Human Services | $54.8M | 3 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| ASPR/ORM-SNS | $33.4M | 1 |
| BARDA - ASPR / DAAPPO / BARDA DCMA | $21.4M | 2 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325412 — Pharmaceutical Preparation Manufacturing | $33.4M | 1 |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | $21.4M | 2 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $33.4M | 1 |
| AN44 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; R&D ADMINISTRATIVE EXPENSES | $12.0M | 1 |
| AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $9.4M | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $54.8M | 3 |
States
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $54.8M | 3 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $54.8M | 3 |